Hoth Therapeutics Announces Positive Preclinical End Point Results of HT-ALZ Treatment for Alzheimer’s Disease
- Wednesday, August 9, 2023, 7:14
- Business
- Add a comment
HT-ALZ Showed Improvement on Several Tests of Cognitive Function HT-ALZ Showed Positive Benefits with Reductions in Anxiety Completed Dose Response Study Leads Hoth to Begin Formulation Development NEW YORK, Aug. 9, 2023 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a…
About the Author
adminasapcorp has written 38955 stories on this site.